hrp 102 has been researched along with Postpartum Amenorrhea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JK; Chen, SF; Fang, KJ; Ge, JL; Ge, RS; He, ML; Luo, SY; Sang, GW; Shao, QX; Song, S | 1 |
| Albrecht, G; Arboleda, C; Bailon, R; Bassol, S; Bucheli, R; Carneiro de Oliveira, H; Carranza, S; Castañeda, A; Celis, C; Chada, E; Cravioto, MC; de Andrade, ME; de Mello, NR; de Melo, K; Durand, M; Fugarolas, J; Gaona, R; Garza-Flores, J; Gomez, P; Gurucharri, C; Hidalgo, I; Lopez, C; Mendez, J; Novelli, J; Olavide, R; Parada, LM; Parejarios, J; Reyes-Marquez, R; Santoyo, S; Succar, J; Trujillo, L; Vazquez, L; Yassle, ME | 1 |
2 trial(s) available for hrp 102 and Postpartum Amenorrhea
| Article | Year |
|---|---|
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Patient Dropouts | 1995 |
Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Humans; Injections; Latin America; Norethindrone; Pregnancy; Uterine Hemorrhage; Weight Gain | 2000 |